{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:57:10Z","timestamp":1770983830135,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,24]],"date-time":"2018-02-24T00:00:00Z","timestamp":1519430400000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["153377"],"award-info":[{"award-number":["153377"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009070","name":"Hans-Sigrist-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jgar.2016.12.013","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T05:48:00Z","timestamp":1487656080000},"page":"179-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["In vitro activity of three commercial bacteriophage cocktails against multidrug-resistant Escherichia coli and Proteus spp. strains of human and non-human origin"],"prefix":"10.1016","volume":"8","author":[{"given":"Odette J.","family":"Bernasconi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regula","family":"Tinguely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-5421","authenticated-orcid":false,"given":"Andrea","family":"Endimiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2016.12.013_bib0005","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/jac\/dkt208","article-title":"Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland","volume":"68","author":"Seiffert","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drup.2012.12.001","article-title":"Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?","volume":"16","author":"Seiffert","year":"2013","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jgar.2016.12.013_bib0015","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1128\/AAC.01773-13","article-title":"High prevalence of extended-spectrum-cephalosporin-resistant Enterobacteriaceae in poultry meat in Switzerland: emergence of CMY-2- and VEB-6-possessing Proteus mirabilis","volume":"57","author":"Seiffert","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods","volume":"7","author":"Lee","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0025","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/AAC.00731-16","article-title":"Travelers can import colistin-resistant Enterobacteriaceae, including those possessing the plasmid-mediated mcr-1 gene","volume":"60","author":"Bernasconi","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/tan.12742","article-title":"Back to the future: bacteriophages as promising therapeutic tools","volume":"87","author":"Domingo-Calap","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.jgar.2016.12.013_bib0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev-virology-100114-054915","article-title":"Bacteriophage therapy: advances in formulation strategies and human clinical trials","volume":"2","author":"Vandenheuvel","year":"2015","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0040","first-page":"347","article-title":"Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum \u03b2-lactamase-producing Escherichia coli bacteremia","volume":"17","author":"Wang","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jgar.2016.12.013_bib0045","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/jac\/dkw253","article-title":"Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex","volume":"71","author":"Dufour","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0050","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.06330-11","article-title":"Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15","volume":"56","author":"Pouillot","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0055","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/jac\/dkt453","article-title":"Susceptibility of extended-spectrum- \u03b2-lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages","volume":"69","author":"Fitzgerald-Hughes","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fmicb.2016.00465","article-title":"Bacteriophages as potential treatment for urinary tract infections","volume":"7","author":"Sybesma","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0065","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3389\/fmicb.2016.01761","article-title":"In vitro effectiveness of commercial bacteriophage cocktails on diverse extended-spectrum \u03b2-lactamase producing Escherichia coli strains","volume":"7","author":"Gundogdu","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.diagmicrobio.2012.01.004","article-title":"First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland","volume":"73","author":"Endimiani","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2016.12.013_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mimet.2016.01.002","article-title":"Comparison of the in-house made Carba-NP and Blue-Carba tests: considerations for better detection of carbapenemase-producing Enterobacteriaceae","volume":"122","author":"Pires","year":"2016","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.jgar.2016.12.013_bib0080","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fmicb.2016.01069","article-title":"Polyclonal intestinal colonization with extended-spectrum cephalosporin-resistant Enterobacteriaceae upon traveling to India","volume":"7","author":"Pires","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0085","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1128\/AAC.02417-13","article-title":"OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland","volume":"58","author":"Seiffert","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijantimicag.2016.08.007","article-title":"Intestinal colonisation with extended-spectrum cephalosporin-resistant Escherichia coli in Swiss pets: molecular features, risk factors and transmission with owners","volume":"48","author":"Pires","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2016.12.013_bib0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2016.12.013_bib0100","article-title":"Bacteriophages. Methods and protocols","volume":"vol. 1","year":"2009"},{"key":"10.1016\/j.jgar.2016.12.013_bib0105","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/jac\/dkw274","article-title":"Transferable resistance to colistin: a new but old threat","volume":"71","author":"Schwarz","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance","volume":"35","author":"Woodford","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jgar.2016.12.013_bib0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrmicro3096","article-title":"Revenge of the phages: defeating bacterial defences","volume":"11","author":"Samson","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0120","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1186\/s13104-015-1687-6","article-title":"Whole genome sequencing provides possible explanations for the difference in phage susceptibility among two Salmonella Typhimurium phage types (DT8 and DT30) associated with a single foodborne outbreak","volume":"8","author":"Mohammed","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jgar.2016.12.013_bib0125","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.3390\/v7122958","article-title":"What can we learn from a metagenomic analysis of a Georgian bacteriophage cocktail?","volume":"7","author":"Zschach","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2016.12.013_bib0130","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s11095-014-1617-7","article-title":"Quality and safety requirements for sustainable phage therapy products","volume":"32","author":"Pirnay","year":"2015","journal-title":"Pharm Res"},{"key":"10.1016\/j.jgar.2016.12.013_bib0135","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0017-2013","article-title":"Proteus mirabilis and urinary tract infections","volume":"3","author":"Schaffer","year":"2015","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2016.12.013_bib0140","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1128\/AAC.49.7.2598-2605.2005","article-title":"Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum \u03b2-lactamases","volume":"49","author":"Endimiani","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0145","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.21.20484-en","article-title":"Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011","volume":"18","author":"Kronenberg","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2016.12.013_bib0150","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00705-016-2944-2","article-title":"Lytic bacteriophage PM16 specific for Proteus mirabilis: a novel member of the genus Phikmvvirus","volume":"161","author":"Morozova","year":"2016","journal-title":"Arch Virol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.18388\/abp.2015_1114","article-title":"Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP","volume":"63","author":"Maszewska","year":"2016","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0160","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fmicb.2016.01024","article-title":"Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections","volume":"7","author":"Melo","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0165","doi-asserted-by":"crossref","first-page":"e0118557","DOI":"10.1371\/journal.pone.0118557","article-title":"Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy","volume":"10","author":"Khan Mirzaei","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2016.12.013_bib0170","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1017\/ice.2016.137","article-title":"National bloodstream infection surveillance in Switzerland 2008\u20132014: different patterns and trends for university and community hospitals","volume":"37","author":"Buetti","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0175","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/AAC.00565-10","article-title":"National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum \u03b2-lactamases","volume":"54","author":"Marchaim","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2016.12.013_bib0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/mdr.2013.0210","article-title":"Occurrence and genetic characteristics of third-generation cephalosporin-resistant Escherichia coli in Swiss retail meat","volume":"20","author":"Vogt","year":"2014","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jgar.2016.12.013_bib0185","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/AEM.00258-15","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae isolated from vegetables imported from the Dominican Republic, India, Thailand, and Vietnam","volume":"81","author":"Zurfluh","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0190","first-page":"19","article-title":"The importance of a One Health approach to preventing the development and spread of antibiotic resistance","volume":"366","author":"Collignon","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jgar.2016.12.013_bib0195","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1002\/jsfa.6222","article-title":"Using lytic bacteriophages to eliminate or significantly reduce contamination of food by foodborne bacterial pathogens","volume":"93","author":"Sulakvelidze","year":"2013","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.jgar.2016.12.013_bib0200","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fmicb.2015.01271","article-title":"On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy","volume":"6","author":"Mattila","year":"2015","journal-title":"Front Microbiol"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517300255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517300255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:52:22Z","timestamp":1761990742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716517300255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":40,"alternative-id":["S2213716517300255"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2016.12.013","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of three commercial bacteriophage cocktails against multidrug-resistant Escherichia coli and Proteus spp. strains of human and non-human origin","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2016.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}